Manman Tian - Ctr Comprehens Canc, Nanjing Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Mycobacterium Smegmatis Enhances Shikonin-Induced Immunogenic Cell Death—an Efficient in Situ Tumor Vaccine Strategy

Zhaoye Qian, Zhe Zhang,Lanqi Cen,Yaohua Ke,Jie Shao,Manman Tian,Baorui Liu

The Journal of Biomedical Researchpp.369-381, (2024)

引用0浏览0WOS引用

Design of a Single-Center, Phase II Trial to Explore the Efficacy and Safety of 'R-ISV-RO' Treatment in Advanced Tumors

Limei Min,Xiaolu Wang,Anni Chen, Yingling Zhou, Yuchen Ge, Juanjuan Dai,Xiaofeng Chang,Wu Sun,Qin Liu, Xia Zhou,Manman Tian,Wentao Kong,Junmeng Zhu,Jie Shen,Baorui Liu,Rutian Li

Future oncology (London, England)no. 17 (2024): 1139-1149

引用0浏览0WOS引用

Efficacy of MAGE-A4 Long Peptide As a Universal Immunoprevention Cancer Vaccine

Lanqi Cen, Zhe Zhang,Yi Sun,Nandie Wu,Jie Shao,Zhaoye Qian,Manman Tian, Yaohua Ke,Baorui Liu

CANCER CELL INTERNATIONALno. 1 (2024)

引用0浏览0WOS引用

Abstract 5001: Personalized Neoantigen/cancer-Testis Antigen Nanovaccine for Advanced Solid Tumors, a Single-Arm, Open-Label Pilot Study

Jia Wei,Qin Liu,Lijing Zhu,Jie Shao,Ju Yang,Guanghui Xu,Nandie Wu,Hanbing Wang,Rutian Li, Huizi Sha,Qiuping Xu,Jie Shen,Li Xie,Lifeng Wang,Juan Du,Lanqi Cen,Manman Tian,Lixia Yu,Baorui Liu

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

An Investigator-Initiated Clinical Study in Patients with Refractory or Recurrent Solid Tumors: 'R-Isv-folactis' Trial

Juanjuan Dai,Junmeng Zhu,Lijing Zhu,Xiaolu Wang, Jinfeng Bao,Xinjie Chen, Yingling Zhou, Limei Min, Haoyue Qi,Qin Liu,Jie Shen,Manman Tian,Jie Shao,Rutian Li,Baorui Liu

Future Oncologypp.1-8, (2024)

引用0浏览0WOS引用

Combining Irgd with HuFOLactis Enhances Antitumor Potency by Facilitating Immune Cell Infiltration and Activation

Jie Shao,Kai Xin,Zhaoye Qian,Fangcen Liu,Lin Li,Junmeng Zhu,Qin Liu,Manman Tian,Baorui Liu

HUMAN VACCINES & IMMUNOTHERAPEUTICSno. 1 (2024)

引用0浏览0WOS引用

An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial

Jing Dai,Xiaolu Wang,Xinjie Chen, Jianguo Zhu, Yingling Zhou, Min Li, Hui Qi,Qin Liu,Jie Shen,Manman Tian,Jie Shao,Baorui Liu,Rutian Li

Research Square (Research Square) (2023)

引用0浏览0引用

Irgd-Modified Memory-Like NK Cells Exhibit Potent Responses to Hepatocellular Carcinoma

Yanbing Dong, Ying Huang, Zhe Zhang,Aoxing Chen,Lin Li,Manman Tian,Jie Shen,Jie Shao

Journal of Translational Medicine (2023)

引用2浏览0WOS引用

Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors

Xinyue Wang,Fanyan Meng, Xiang Li, Luxin Xue,Anni Chen,Yuling Qiu, Zhifan Zhang,Lin Li, Fengcen Liu,Yishan Li,Zhichen Sun,Yanhong Chu,Ruihan Xu,Lixia Yu,Jie Shao,Manman Tian,Xiaoping Qian,Qin Liu,Baorui Liu,Rutian Li

Advanced science（2023）

引用1浏览0WOS引用

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer (adv. Sci. 1/2023)

Qin Liu,Yanhong Chu,Jie Shao,Hanqing Qian,Ju Yang,Huizi Sha,Lanqi Cen,Manman Tian,Qiuping Xu,Fangjun Chen, Yang,Weifeng Wang,Kai Wang,Lixia Yu,Jia Wei,Baorui Liu

Advanced Scienceno. 1 (2023)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn